WP Leader: Prof. Sabastien Ourselin, University College London
Numerous studies in Alzheimer’s disease and related dementias have been performed in order to identify the most promising biomarkers for early detection of the disease, monitoring disease progression, and measuring the effectiveness of potential treatments during clinical trials. These initiatives have collected substantial amounts of imaging, cognitive, fluid, lifestyle, and genetic data on the healthy ageing, those who have memory problems and likely to develop dementia, and patients affected by Alzheimer’s and other dementias.
This work package, combines all of this information and extracts relevant image-based biomarkers using existing, well-validated tools in order to provide the most comprehensive set of data on the disease process.
This data will then serve as inputs for the models that will be constructed in other work packages.